SWAV Overzicht aandelen
A medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 1/6 |
| Toekomstige groei | 3/6 |
| Prestaties in het verleden | 3/6 |
| Financiële gezondheid | 5/6 |
| Dividenden | 0/6 |
Shockwave Medical, Inc. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$334.75 |
| 52 Week Hoogtepunt | US$334.90 |
| 52 Week Laag | US$157.00 |
| Bèta | 0.88 |
| 11 maand verandering | 1.49% |
| 3 maanden verandering | 27.08% |
| 1 Jaar Verandering | 15.77% |
| 33 jaar verandering | 97.43% |
| 5 jaar verandering | 432.11% |
| Verandering sinds IPO | 997.54% |
Recent nieuws en updates
Recent updates
Shockwave Medical, Inc.'s (NASDAQ:SWAV) 28% Jump Shows Its Popularity With Investors
Apr 06
Is Now An Opportune Moment To Examine Shockwave Medical, Inc. (NASDAQ:SWAV)?
Mar 24Shockwave Medical: Opening Arteries, Delivering Returns
Feb 28Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Feb 18There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital
Feb 06Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)
Jan 24Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio
Jan 09Is Shockwave Medical (NASDAQ:SWAV) A Risky Investment?
Dec 27Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?
Dec 13What Is Shockwave Medical, Inc.'s (NASDAQ:SWAV) Share Price Doing?
Nov 17Is Shockwave Medical, Inc. (NASDAQ:SWAV) Trading At A 50% Discount?
Oct 19Shockwave Medical (NASDAQ:SWAV) Is Very Good At Capital Allocation
Oct 06Shockwave Medical (NASDAQ:SWAV) Has A Rock Solid Balance Sheet
Sep 20Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?
Sep 07When Should You Buy Shockwave Medical, Inc. (NASDAQ:SWAV)?
Jul 10We Think Shockwave Medical (NASDAQ:SWAV) Might Have The DNA Of A Multi-Bagger
Jun 26We Think Shockwave Medical (NASDAQ:SWAV) Can Manage Its Debt With Ease
Jun 13Is Now The Time To Put Shockwave Medical (NASDAQ:SWAV) On Your Watchlist?
May 29Rendement voor aandeelhouders
| SWAV | US Medical Equipment | US Markt | |
|---|---|---|---|
| 7D | 0.2% | 1.1% | 2.3% |
| 1Y | 15.8% | 29.2% | 35.1% |
Rendement versus industrie: SWAV overtrof de US Medical Equipment industrie, die het afgelopen jaar een rendement 29.2 % opleverde.
Rendement versus markt: SWAV presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 35.1 % opleverde.
Prijsvolatiliteit
| SWAV volatility | |
|---|---|
| SWAV Average Weekly Movement | 3.6% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 2.9% |
Stabiele aandelenkoers: SWAV heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van SWAV is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2009 | 1,468 | Doug Godshall | shockwavemedical.com |
Shockwave Medical, Inc. Samenvatting
| SWAV fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$12.57b |
| Inkomsten(TTM) | US$163.50m |
| Inkomsten(TTM) | US$787.97m |
76.9x
Koers/Winstverhouding15.9x
P/S-verhoudingIs SWAV overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| SWAV resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$787.97m |
| Kosten van inkomsten | US$102.53m |
| Brutowinst | US$685.44m |
| Overige uitgaven | US$521.94m |
| Inkomsten | US$163.50m |
Laatst gerapporteerde inkomsten
Mar 31, 2024
Volgende inkomensdatum
Aug 05, 2024
| Winst per aandeel (EPS) | 4.35 |
| Brutomarge | 86.99% |
| Nettowinstmarge | 20.75% |
| Schuld/Eigen Vermogen Verhouding | 97.5% |
Hoe presteerde SWAV op de lange termijn?
Bekijk historische prestaties en vergelijking